SCHEMBL14164243

SCHEMBL14164243

COC(=O)c1cnc(C(=O)O)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.50
KDM4E B2RXH2 4/20 0.43
MAPK1 P28482 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
KDM6B O15054 1/20 0.41
KDM5C P41229 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
KDM2A Q9Y2K7 1/20 0.41
KDM3A Q9Y4C1 1/20 0.41
FFAR2 O15552 1/20 0.41
NPSR1 Q6W5P4 2/20 0.41
NCOA1 Q15788 2/20 0.41
NCOA3 Q9Y6Q9 2/20 0.41
LMNA P02545 1/20 0.41
PPARG P37231 1/20 0.41
NCOA2 Q15596 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.38
CSNK2A2 P19784 1/20 0.38
KDR P35968 1/20 0.38
CSNK2B P67870 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21836283 0.85 ALDH1A1 (0.42) HCAR2KDM4EMAPK1L3MBTL1FFAR2
SCHEMBL1810308 0.83 HCAR2 (0.61) HCAR2KDM4EFFAR2PRKAB2PRKAG1
SCHEMBL21448921 0.83 FFAR2 (0.43) HCAR2KDM4EMAPK1L3MBTL1FFAR2
SCHEMBL5196234 0.83 FFAR2 (0.40) HCAR2KDM4EMAPK1L3MBTL1FFAR2
SCHEMBL21244224 0.81 CDC7 (0.41) HCAR2KDM4EMAPK1L3MBTL1FFAR2
Hydrochloric Acid SCHEMBL11597191 0.81 HCAR2 (0.59) HCAR2KDM4EFFAR2PRKAB2PRKAG1
SCHEMBL1107386 0.78 HCAR2 (0.68) HCAR2KDM4EMAPK1L3MBTL1FFAR2
SCHEMBL472995 0.78 CSNK2A2 (0.42) HCAR2KDM4EMAPK1L3MBTL1FFAR2
SCHEMBL4292895 0.78 HCAR2 (0.42) HCAR2KDM4EMAPK1L3MBTL1FFAR2
SCHEMBL17204603 0.78 HCAR2 (0.50) HCAR2KDM4ELMNAALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3564239-B9 ARYL HYDROCARBON RECEPTOR MODULATOR ARIAGEN INC (US) 2023-04-19 EP disclosed
US-11547698-B2 Aryl hydrocarbon receptor modulators ARIAGEN, INC. (US) 2023-01-10 US disclosed
EP-3564239-A1 ARYL HYDROCARBON RECEPTOR MODULATOR Shenzhen Immunova Pharmaceutical Co., Ltd. (CN) 2019-11-06 EP disclosed
US-20190330201-A1 ARYL HYDROCARBON RECEPTOR MODULATORS AHR PHARMACEUTICALS, INC. 2019-10-31 US disclosed
US-20190307731-A1 ARYL HYDROCARBON RECEPTOR MODULATOR ARIAGEN, INC. (US) 2019-10-10 US disclosed
US-20080139535-A1 INHIBITORS OF HISTONE DEACETYLASE MIIKANA THERAPEUTICS 2008-06-12 US disclosed
US-20080139535-A1 INHIBITORS OF HISTONE DEACETYLASE MIIKANA THERAPEUTICS 2008-06-12 US disclosed
US-7345043-B2 Inhibitors of histone deacetylase MIIKANA THERAPEUTICS (US) 2008-03-18 US disclosed
US-7345043-B2 Inhibitors of histone deacetylase MIIKANA THERAPEUTICS (US) 2008-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190307731-A1 ARYL HYDROCARBON RECEPTOR MODULATOR AHR, ARNT, NR1H4 HCAR2 15/4885KDM4E 2566/4885MAPK1 2104/4885
US-11547698-B2 Aryl hydrocarbon receptor modulators AHR, ARNT, CNR1 HCAR2 14/4885KDM4E 2197/4885MAPK1 2641/4885
US-20190330201-A1 ARYL HYDROCARBON RECEPTOR MODULATORS AHR, ARNT, CNR1 HCAR2 14/4885KDM4E 2197/4885MAPK1 2641/4885
US-20080139535-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC10 HCAR2 1963/4885KDM4E 764/4885MAPK1 3069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.